Breast screening in the Netherlands seems to have had a marginal effect on breast cancer mortality over the past 24 years, suggests research in The BMJ. Their findings show that screening would be associated with up to 5% reductions in breast cancer mortality in women aged 50 and over, whereas improved treatments would be associated with a 28% reduction. And they point out that over diagnosis “has steadily increased over time” with the extension of screening to women aged 70-75 and with the introduction of digital mammography.
See original article at: https://www.sciencedaily.com/releases/2017/12/171205203050.htm
Post a comment